Elyxium Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Elyxium Wealth's GILD Position: Q3 2026 in Review
Elyxium Wealth increased its Gilead Sciences (GILD) stake by 9.1% in Q3 2026, buying an estimated $44.9K and bringing the position to 3,822 shares worth $570K. The position accounts for 0.06% of the portfolio, ranked #168.
Elyxium Wealth first reported a position in GILD in Q1 2025 and has held it in 7 quarters since. 2,349 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Elyxium Wealth held 3,822 shares of Gilead Sciences worth $570K as of Q3 2026.
- Elyxium Wealth bought 320 Gilead Sciences shares in Q3 2026, an estimated $44.9K.
- Gilead Sciences made up 0.06% of Elyxium Wealth's portfolio in Q3 2026, its #168 holding.
- Elyxium Wealth first reported a position in Gilead Sciences in Q1 2025 and has held it in 7 quarters since.
- 2,349 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.